Get the Stockscreener App
1.0199
7.36%
0.0699
Fibrobiologics Inc stock is traded at $1.0199, with a volume of 116.55K.
It is up +7.36% in the last 24 hours and down -29.17% over the past month.
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
See More
Previous Close:
$0.95
Open:
$0.96
24h Volume:
116.55K
Relative Volume:
0.82
Market Cap:
$7.22M
Revenue:
Net Income/Loss:
$-18.68M
P/E Ratio:
-0.1379
EPS:
-7.3948
Net Cash Flow:
$-15.70M
1W Performance:
-8.12%
1M Performance:
-29.17%
6M Performance:
-33.77%
1Y Performance:
-88.67%
1-Day Range:
$0.96
$1.05
1-Week Range:
$0.9247
$1.20
52-Week Range:
$0.6201
$9.654
Fibrobiologics Inc Stock (FBLG) Company Profile
Name
Fibrobiologics Inc
Sector
Industry
Phone
281-671-5150
Address
455 E. MEDICAL CENTER BLVD, HOUSTON
Compare FBLG vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
1.0199 | 7.22M | 0 | -18.68M | -15.70M | -7.3948 |
VRTX
Vertex Pharmaceuticals Inc
|
508.46 | 128.88B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
237.99 | 95.01B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
800.59 | 82.42B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
849.61 | 53.43B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
372.06 | 42.09B | 5.76B | 514.49M | 1.10B | 4.4813 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-24 | Initiated | H.C. Wainwright | Buy |
| Sep-24-24 | Initiated | Maxim Group | Buy |
Fibrobiologics Inc Stock (FBLG) Latest News
A 15% discount accompanies FibroBiologics (FBLG)'s zero-interest debt deal. - Stock Titan
FibroBiologics Shareholders Approve Potential Warrant-Driven Share Issuance - The Globe and Mail
FibroBiologics (NASDAQ: FBLG) raises $0.5M in insider deal - Stock Titan
Hamid Khoja Discloses Investment at FibroBiologics with 7.5% Stake - tradingview.com
Private deal gives FibroBiologics (FBLG) CSO hundreds of thousands of shares - Stock Titan
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer - tradingview.com
FibroBiologics (FBLG) turns to a private stock-and-warrant deal for new funding - Stock Titan
FibroBiologics Announces Insider Private Placement Financing - The Globe and Mail
FibroBiologics Announces Insider Private Placement Financing - The Globe and Mail
FibroBiologics (FBLG) CSO to buy new shares and warrants in private deal - Stock Titan
Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications - ACCESS Newswire
Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications - guardonline.com
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing - Yahoo Finance
FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media - Morningstar
A new patent covers a way to promote repair in damaged spinal discs from FibroBiologics. - Stock Titan
FibroBiologics ships new batch of diabetic ulce... - Pluang
FibroBiologics ships third batch of trial drug to Australia - Investing.com
FibroBiologics ships third batch of trial drug to Australia By Investing.com - Investing.com India
FibroBiologics ships third batch of trial drug to Australia By Investing.com - Investing.com UK
FibroBiologics ships a third batch of wound treatment being tested to Australia - Stock Titan
FibroBiologics regains Nasdaq bid price compliance - Investing.com
FibroBiologics Adds Sports Agent Leigh Steinberg to Board of Directors - citybiz
FibroBiologics appoints Leigh Steinberg to board By Investing.com - Investing.com Canada
FibroBiologics appoints Leigh Steinberg to board By Investing.com - Investing.com India
Leigh Steinberg, agent behind $4B in deals, joins FibroBiologics (FBLG) board - Stock Titan
FibroBiologics appoints Leigh Steinberg to board By Investing.com - Investing.com UK
Fibro appoints Leigh Steinberg as Class II director - TradingView
FibroBiologics | 10-Q: Q1 2026 Earnings Report - Moomoo
FibroBiologics receives Australian patent for disc disease therapy - Investing.com
FibroBiologics receives Australian patent for disc disease therapy By Investing.com - Investing.com Canada
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease - Morningstar
FibroBiologics receives Australian patent for disc disease therapy By Investing.com - Investing.com UK
FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease - PR Newswire
FibroBiologics receives Australian patent for disc disease therapy - Investing.com India
FibroBiologics Says Preclinical Data Shapes Design of Further Studies for Degenerative Joint Treatment - Sahm
FibroBiologics Says Preclinical Data Shapes Design of Further Studies for Degenerative Joint Treatment - Benzinga
FibroBiologics reports cartilage repair in animal study By Investing.com - Investing.com South Africa
FibroBiologics reports cartilage repair in animal study - Investing.com
FibroBiologics reports cartilage repair in animal study By Investing.com - Investing.com Nigeria
FibroBiologics reports cartilage repair in animal study By Investing.com - Investing.com Canada
FibroBiologics reports cartilage repair in animal study By Investing.com - Investing.com UK
FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints - PR Newswire
FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints - Yahoo Finance
Armistice Capital discloses 9.99% FibroBiologics (FBLG) stake via Master Fund - Stock Titan
FibroBiologics Inc - Smartkarma
FBLG Q2 2026 Earnings: Narrower Loss Beats Estimates as Pre-Revenue Biotech Advances Fibroblast Pipeline - vinanet.vn
FBLG Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 7.77% Share GainEarnings Surprise Stocks - vinanet.vn
FibroBiologics receives patent for islet transplant method By Investing.com - Investing.com UK
FibroBiologics receives patent for islet transplant method By Investing.com - Investing.com Australia
FibroBiologics receives patent for islet transplant method - Investing.com
Fibrobiologics Inc Stock (FBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fibrobiologics Inc Stock (FBLG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| O'HEERON PETE | CHIEF EXECUTIVE OFFICER |
Mar 04 '26 |
Buy |
0.38 |
15,872 |
6,006 |
5,958,147 |
| O'HEERON PETE | CHIEF EXECUTIVE OFFICER |
Mar 03 '26 |
Buy |
0.41 |
18,200 |
7,373 |
5,942,275 |
| O'HEERON PETE | CHIEF EXECUTIVE OFFICER |
Mar 02 '26 |
Buy |
0.35 |
17,428 |
6,152 |
5,924,075 |
| Davis Jason | Chief Financial Officer |
Mar 02 '26 |
Buy |
0.41 |
70,000 |
28,973 |
70,000 |
| GARCIA RUBEN A | General Counsel |
Feb 27 '26 |
Buy |
0.33 |
40,000 |
13,056 |
180,000 |
| GARCIA RUBEN A | General Counsel |
Dec 11 '25 |
Buy |
0.34 |
140,000 |
47,600 |
140,000 |
3.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):